172 related articles for article (PubMed ID: 9710953)
1. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
2. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
[TBL] [Abstract][Full Text] [Related]
3. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
4. Human serum butyrylcholinesterase: in vitro and in vivo stability, pharmacokinetics, and safety in mice.
Saxena A; Sun W; Luo C; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():199-203. PubMed ID: 16263104
[TBL] [Abstract][Full Text] [Related]
5. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
7. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.
Broomfield CA; Maxwell DM; Solana RP; Castro CA; Finger AV; Lenz DE
J Pharmacol Exp Ther; 1991 Nov; 259(2):633-8. PubMed ID: 1941611
[TBL] [Abstract][Full Text] [Related]
8. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
[TBL] [Abstract][Full Text] [Related]
9. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
Maxwell DM; Koplovitz I
J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
11. Protection of guinea pigs against soman poisoning by pretreatment with p-nitrophenyl phosphoramidates.
Langenberg JP; De Jong LP; Benschop HP
Toxicol Appl Pharmacol; 1996 Oct; 140(2):444-50. PubMed ID: 8887462
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of human butyrylcholinesterase pretreatment followed by acute soman challenge in cynomolgus monkeys.
Sun W; Doctor BP; Lenz DE; Saxena A
Chem Biol Interact; 2008 Sep; 175(1-3):428-30. PubMed ID: 18674756
[TBL] [Abstract][Full Text] [Related]
13. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs.
Perkins MW; Pierre Z; Rezk P; Sabnekar P; Kabra K; Chanda S; Oguntayo S; Sciuto AM; Doctor BP; Nambiar MP
Toxicol Appl Pharmacol; 2010 Jun; 245(2):171-8. PubMed ID: 20206646
[TBL] [Abstract][Full Text] [Related]
14. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor.
Langenberg JP; Spruit HE; van der Wiel HJ; Trap HC; Helmich RB; Bergers WW; van Helden HP; Benschop HP
Toxicol Appl Pharmacol; 1998 Jul; 151(1):79-87. PubMed ID: 9705889
[TBL] [Abstract][Full Text] [Related]
15. Endotracheal aerosolization of atropine sulfate protects against soman-induced acute respiratory toxicity in guinea pigs.
Perkins MW; Pierre Z; Rezk P; Song J; Marshall S; Oguntayo S; Morthole V; Sciuto AM; Doctor BP; Nambiar MP
Inhal Toxicol; 2011 Mar; 23(4):182-95. PubMed ID: 21456952
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs.
Valiyaveettil M; Alamneh Y; Rezk P; Biggemann L; Perkins MW; Sciuto AM; Doctor BP; Nambiar MP
Biochem Pharmacol; 2011 Mar; 81(6):800-9. PubMed ID: 21219877
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
Lau WM; Lewis KJ; Dawson RM
J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
[TBL] [Abstract][Full Text] [Related]
18. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
19. Human plasma-derived butyrylcholinesterase is behaviorally safe and effective in cynomolgus macaques (Macaca fascicularis) challenged with soman.
Myers TM
Chem Biol Interact; 2019 Aug; 308():170-178. PubMed ID: 31129133
[TBL] [Abstract][Full Text] [Related]
20. A novel tertiary pyridostigmine derivative [3-(N,N-dimethylcarbamyloxy)-1-methyl-delta 3-tetrahydropyridine]: anticholinesterase properties and efficacy against soman.
Ray R; Clark OE; Ford KW; Knight KR; Harris LW; Broomfield CA
Fundam Appl Toxicol; 1991 Feb; 16(2):267-74. PubMed ID: 2055358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]